PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.61%
Positive revenue growth while 3391.T is negative. John Neff might see a notable competitive edge here.
7.07%
Positive gross profit growth while 3391.T is negative. John Neff would see a clear operational edge over the competitor.
23.00%
Positive EBIT growth while 3391.T is negative. John Neff might see a substantial edge in operational management.
18.46%
Positive operating income growth while 3391.T is negative. John Neff might view this as a competitive edge in operations.
42.27%
Positive net income growth while 3391.T is negative. John Neff might see a big relative performance advantage.
42.25%
Positive EPS growth while 3391.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
42.25%
Positive diluted EPS growth while 3391.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Share reduction while 3391.T is at 0.01%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
22.22%
Dividend growth of 22.22% while 3391.T is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
65.40%
10Y revenue/share CAGR under 50% of 3391.T's 199.54%. Michael Burry would suspect a lasting competitive disadvantage.
61.06%
5Y revenue/share CAGR at 75-90% of 3391.T's 72.26%. Bill Ackman would encourage strategies to match competitor’s pace.
34.47%
3Y revenue/share CAGR 1.25-1.5x 3391.T's 30.55%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 100.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
155.91%
Below 50% of 3391.T's 388.37%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
137.88%
5Y net income/share CAGR above 1.5x 3391.T's 55.75%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
84.91%
3Y net income/share CAGR above 1.5x 3391.T's 47.78%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
215.84%
10Y equity/share CAGR in line with 3391.T's 200.04%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
132.15%
5Y equity/share CAGR above 1.5x 3391.T's 73.91%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
65.78%
3Y equity/share CAGR above 1.5x 3391.T's 33.68%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-8.33%
Cut dividends over 10 years while 3391.T stands at 80105.38%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-8.33%
Negative 5Y dividend/share CAGR while 3391.T stands at 97.37%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
57.14%
3Y dividend/share CAGR above 1.5x 3391.T's 17.19%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
34.92%
AR growth well above 3391.T's 5.59%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.59%
Inventory growth well above 3391.T's 1.64%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.03%
Asset growth 1.25-1.5x 3391.T's 4.44%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
4.95%
BV/share growth above 1.5x 3391.T's 2.86%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-10.52%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-45.14%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.